- 109.7k views
Total Anomalous Pulmonary Venous Connection- Overview
Total anomalous pulmonary venous connection (TAPVC) is a condition in which, with or without pulmonary venous blockage, all four pulmonary veins drain into systemic veins or the right atrium. In the right atrium, systemic and pulmonary venous blood are mixed. In both foetal and newborn circulation, the presence of an atrial defect or foramen ovale (a component of the complex) is significant for left ventricular output. TAPVR and PAPVR may be detected during pregnancy, however this is less common than discovering them immediately after a baby is delivered. TAPVR babies will require surgery to correct the flaw. The severity of the child's illness and the precise design of the atypical connections between the pulmonary veins and the right atrium determine the age at which the surgery is performed. Normal blood flow through the heart will be restored as a result of the surgical TAPVR correction. In order to correct this problem, clinicians typically join the pulmonary veins to the left atrium, block any unnatural blood vessel connections, and seal the atrial septal defect. Infants with surgically corrected abnormalities may experience lifelong consequences; they are not necessarily cured. A cardiologist (a physician who specialises in the heart) will need to see a kid or adult with TAPVR on a regular basis to check on their progress, prevent problems, and assess their heart.
About the Speaker
Dr. Prabhata Rashmi
Sr. consultant & HOD of Pediatric Cardiac Surgery
Upcoming Case Discussions
Treatment of Renal Disease in ANCA Vasculitis
The treatment of renal disease in ANCA-associated vasculitis (AAV) typically involves a combination of immunosuppressive therapies to control inflammation and prevent further kidney damage. First-line treatment often includes high-dose corticosteroids and cyclophosphamide or rituximab, both of which help to induce remission by targeting the underlying immune system dysfunction. In cases of kidney failure or rapidly progressive glomerulonephritis, plasmapheresis may be used to remove circulating autoantibodies. Once remission is achieved, maintenance therapy with lower doses of immunosuppressants, such as azathioprine or mycophenolate mofetil, is used to prevent relapses and preserve kidney function.
Pulmonary Tuberculosis: Challenges in Diagnosis
Diagnosing pulmonary tuberculosis (TB) poses significant challenges, particularly in resource-limited settings. The disease often mimics other respiratory conditions, leading to delayed or missed diagnoses. Traditional diagnostic methods like sputum smear microscopy have limited sensitivity, especially in HIV co-infected or low-bacterial-load patients. Advanced techniques such as GeneXpert and culture tests, though more accurate, are often unavailable in remote areas. Children and immunocompromised patients present additional hurdles due to atypical symptoms and difficulty obtaining diagnostic samples. Non-specific imaging findings further complicate diagnosis. Addressing these challenges requires expanded access to molecular diagnostics, improved point-of-care tools, and greater healthcare awareness.
NIV in Acute Respiratory Failure
Dr Viny Kantroo is a Chest, Critical Care & Sleep medicine specialist based in Delhi, boasting over more than 15 years of professional experience. She is currently practising as a full time Senior consultant in Indraprastha Apollo Hospitals New Delhi and Visiting Consultant Apollo Hospitals Noida in the department of Respiratory, Critical Care and Sleep Medicine. She is recognised for her expertise in various aspects of Chest medicine, which includes EBUS (Convex probe, Radial), Bronchoscopic procedures, pleural effusion management, interstitial lung disease, Covid-19, lung cancer, pneumonia, and intensive care patient management. Dr Kantroo is renowned not only for her medical proficiency but also for her empathy and positive attitude towards patient care. Patients consulting with Dr Viny can be assured of receiving an accurate diagnosis and effective treatment, thanks to her commitment to prompt and comprehensive care.
AI in Genetics and Genomics
AI is revolutionizing genetics and genomics by enabling faster and more accurate analysis of complex genetic data. Machine learning algorithms can identify patterns in DNA sequences, helping to discover new genetic variants linked to diseases. Additionally, AI assists in predicting gene functions, personalizing medicine, and accelerating drug development. Its integration promises significant advancements in understanding genetic diseases and improving healthcare outcomes.
Management of Pediatric Type 1 Diabetes
Pediatric type 1 diabetes management focuses on maintaining glycemic control while supporting normal growth. Insulin therapy, via multiple daily injections or pumps, is essential, with doses adjusted based on blood glucose monitoring or continuous glucose monitoring (CGM). Nutrition plans emphasizing carbohydrate counting and balanced meals are crucial, alongside adjustments for physical activity to prevent glucose fluctuations. Education for families on recognizing hypo- and hyperglycemia symptoms and managing sick days is vital. Regular follow-ups with a pediatric endocrinologist help monitor HbA1c levels, growth, and complications. Psychosocial support is key for ensuring adherence and addressing emotional challenges.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Prabhata Rashmi's Talks on Assimilate
- 16-September-2022 , Time: 5PM to 6PM
- 0
Total anomalous pulmonary venous connection (TAPVC) is a condition in which, with or without pulmonary venous blockage, all four pulmonary veins drain into systemic veins or the right atrium. In the right atrium, systemic and pulmonary venous blood are mixed. In both foetal and newborn circulation, the presence of an atrial defect or foramen ovale (a component of the complex) is significant for left ventricular output. TAPVR and PAPVR may be detected during pregnancy, however this is less common than discovering them immediately after a baby is delivered. TAPVR babies will require surgery to correct the flaw. The severity of the child's illness and the precise design of the atypical connections between the pulmonary veins and the right atrium determine the age at which the surgery is performed. Normal blood flow through the heart will be restored as a result of the surgical TAPVR correction. In order to correct this problem, clinicians typically join the pulmonary veins to the left atrium, block any unnatural blood vessel connections, and seal the atrial septal defect. Infants with surgically corrected abnormalities may experience lifelong consequences; they are not necessarily cured. A cardiologist (a physician who specialises in the heart) will need to see a kid or adult with TAPVR on a regular basis to check on their progress, prevent problems, and assess their heart.